NeuroPace Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeuroPace Inc
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
/ 
Frequently asked questions
To buy NeuroPace Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NeuroPace Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NeuroPace Inc is NPCE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NeuroPace Inc has its primary listing on NASDAQ. You can trade NeuroPace Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NeuroPace Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include NeuroPace Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like NeuroPace Inc or others.